Elevated Lipoprotein(a) and Coronary Artery Calcium Score Linked to ASCVD Risk
Investigators examined the independent and joint association of lipoprotein(a) and coronary artery calcium with risk for atherosclerotic cardiovascular disease.
Atherosclerosis
Breast Arterial Calcification May be a Marker for Atherosclerotic Cardiovascular Disease
A study was conducted to determine the relationship between breast arterial calcification and risk for atherosclerotic cardiovascular disease.
A Proteomics Model for Predicting Recurrent ASCVD Risk Outperforms Clinical Risk Model
Researchers evaluated the ability to improve risk stratification of patients with ASCVD via a novel machine-learning model.
Benefits of Smoking Cessation Quantified in Patients With Atherosclerotic CVD
For patients with established atherosclerotic cardiovascular disease, the treatment benefit of smoking cessation is equivalent to the use of targeted pharmaceutical interventions in persistent smokers.
Sex-Based Disparities in Atherosclerotic Cardiovascular Disease Care
Radmila Lyubarova, MD, and Michael G. Nanna, MD, discuss the lack of awareness regarding risk for ASCVD in women and disparities in treatment that they face.
Systolic Hypertension Without Atherosclerosis Increases Risk for Thyroid Cysts
The researchers believe the results of this study highlight the need for an effective screening tool for thyroid cysts among the general population.
Severe NAFLD Associated With High Subclinical Atherosclerosis Risk
The goal of this study was to determine the relationship between subclinical coronary artery disease and the severity of nonalcoholic fatty liver disease.
Lowering LDL-C May Prevent Cardiovascular Disease in Asymptomatic Atherosclerosis
Researchers investigate whether asymptomatic atherosclerotic CVD can be prevented with an aggressive medical treatment that reduces LDL cholesterol to <60 mg/dl.
Inclisiran Safe, Effective in Reducing LDL-C in Patients With Familial Hypercholesterolemia or ASCVD
Researchers conducted a patient-level pooled analysis from phase 3 trials of inclisiran in patients with familial hypercholesterolemia or ASCVD.
Silent Myocardial Infarction Increased Risk for Atherosclerotic Cardiovascular Disease at 10 Years
This study looked at 2946 individuals without cardiovascular disease who were assessed to have intermediate ASCVD risk and underwent electrocardiography.
- Loading...
Loading...
Next post in Cardiovascular and Metabolic Disorders
Loading... 
Loading...